stockrow
Friday 6 November 2026
Export OPK’s income statement to Excel — free account
OPKO Health, Inc.
OPK Healthcare Diagnostics & Research
- Revenue
- −56.9%
- EPS
- −333.3%
- Free cash flow
- −3.40%
- Total debt
- +40.7%
Quarter to September 2026, against a year earlier
1.74
0.01
−0.57%
Follow OPK
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 2 | 3 | 4 |
+8 more TTM periods Free account |
| (12.23%) | (5.88%) | (16.92%) | (17.14%) | ||
| (7.64%) | (3.83%) | (10.69%) | (10.92%) | ||
ROIC |
(6.72%) | (2.45%) | (5.25%) | (5.91%) | |
Return on Tangible Assets |
(20.80%) | (17.26%) | (46.33%) | (44.33%) | |
Average Days of Receivables |
58.36 | 50.84 | 50.02 | 54.28 | |
Free Cash Flow per Share |
(0.18) | (0.18) | (0.23) | (0.25) | |
Free Cash Flow |
(135.01) | (133.73) | (173.96) | (190.53) | |
Capital Expenditures |
(9.97) | (10.35) | (10.66) | (11.99) | |
| Other line items | |||||
Cash ROIC |
(6.86%) | (7.30%) | (9.20%) | (9.63%) | |
Accounts Receivable Turnover |
5.74 | 6.49 | 6.61 | 5.83 | |
Accounts Payable Turnover |
5.46 | 6.53 | 7.19 | 9.09 | |
Inventory Turnover |
4.67 | 5.43 | 5.80 | 6.54 | |
Average Days of Payables |
64.83 | 52.46 | 43.34 | 37.42 | |
Days of Inventory on Hand |
68.46 | 64.83 | 63.18 | 59.92 | |
Tax Rate |
(0.21) | (0.09) | (0.07) | (0.07) | |
Research and Development Expense of Revenue |
25.38% | 21.30% | 21.06% | 20.44% | |
Selling, General and Administrative Expense of Revenue |
35.26% | 35.01% | 36.57% | 36.75% | |
Share Based Compensation of Revenue |
1.97% | 1.85% | 1.86% | 1.77% | |
Interest Coverage |
(2.71) | (1.07) | (0.97) | (1.08) | |
Operating CF/Net income |
0.84 | 1.69 | 0.77 | 0.79 | |
Depreciation/Fixed assets |
1.33 | 1.26 | 1.31 | 1.31 | |
Capex/Depreciation |
(0.11) | (0.11) | (0.11) | (0.12) | |
Revenue per Share |
0.67 | 0.78 | 0.77 | 0.81 | |
Operating CF per Share |
(0.17) | (0.16) | (0.22) | (0.24) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.02) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 4 Nov 2026